MediWound Ltd
15
2
2
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
6.7%
1 terminated/withdrawn out of 15 trials
88.9%
+2.3% vs industry average
27%
4 trials in Phase 3/4
25%
2 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
An Open Label, Single Treatment, Single Arm, Multiple Dose Phase-2 Study to Evaluate the Pharmacokinetics, Safety, and Clinical Performance of EscharEx (EX-03) in Participants With Venous Leg Ulcers
Role: lead
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
Role: lead
Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers
Role: lead
A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
Role: lead
Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries
Role: lead
A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns
Role: lead
A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers
Role: lead
A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers
Role: lead
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
Role: lead
Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns
Role: lead
Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds
Role: lead
Long Term Follow up of Scars Formation and Quality of Life Assessment Study
Role: lead
A Study, Performed in Subjects With Post Traumatic-post Surgical ,Venus Insufficiency and Diabetic Hard to Heal/Chronic Wounds, to Evaluate the Safety and Efficacy of PolyHeal-2 Versus PolyHeal in Once Daily Regimen
Role: lead
Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care
Role: lead
Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care
Role: lead
All 15 trials loaded